General Capillary to Arterial Endothelial Cell Transition in Pulmonary Arterial Hypertension

NIH RePORTER · NIH · R01 · $721,701 · view on reporter.nih.gov ↗

Abstract

Title: General Capillary to Arterial Endothelial Cell Transition in Pulmonary Arterial Hypertension Project Summary Pulmonary arterial hypertension (PAH) is characterized by a progressive increase of pulmonary vascular resistance and obliterative pulmonary vascular remodeling that result in right heart hypertrophy, failure, and premature death. The underlying mechanisms of loss of capillary endothelial cells (ECs) and obliterative vascular lesion formation remain unclear. Our preliminary data showed that arterial programing was evident in human PAH patients and rodents. We hypothesize that general capillary ECs program to arterial ECs through HIF-2-Cdk19/Sox17/Notch4 signaling which contributes to the pathogenesis of PAH. Completing our proposed study will provide a novel therapeutic strategy for the effective treatment of PAH in patients.

Key facts

NIH application ID
10716738
Project number
1R01HL170096-01
Recipient
UNIVERSITY OF ARIZONA
Principal Investigator
Zhiyu Dai
Activity code
R01
Funding institute
NIH
Fiscal year
2023
Award amount
$721,701
Award type
1
Project period
2023-09-15 → 2024-06-30